Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) ...

The European Medicines Agency (EMA) announced on Monday that it will be discontinuing its presence on X, opting instead to utilize rival platform Bluesky.

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

A new method has been created for determining N-nitrosamines (NAs) in pharmaceutical preparations using liquid chromatography ...

The Plastic Surgery Instruments Market is poised for significant growth, with a projected market size of USD 2.68 Billion by ...

A renewed focus on the potentially transformative effect of cell and gene therapies (CGTs) will help businesses developing such treatments to attract investment and persuade policymakers to affect ...

UPDATED: Wednesday, Feb. 5 at 9:05 a.m. ET Novartis' Kisqali has secured a label expansion from the U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA). The new approval covers ...

Pfizer shows profit growth from cost cuts and steadier COVID sales The European medicines regulator ... drugs following a re-evaluation of their supply by the agency. US FDA says Lilly's weight ...

United States Human Rights Violations against the Numu/Nuwu and Newe in the Rush for Lithium,” found that the US Bureau of ...

The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated ...

CHMP Adopts Positive Opinion for Aflibercept, Pegfilgrastim Biosimilars:  On January 30, 2025, the European Medicines Agency (EMA) Committee ...